Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pedal-Assist E-Bikes may boost fitness and cut fat in sedentary students

NCT ID NCT07114991

Disease control Sponsor: University of Wisconsin, River Falls Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether using a pedal-assist electric bike for commuting can improve physical activity, fitness, and health in overweight or obese college students. Participants are randomly assigned to either use an e-bike for at least four trips per week for 12 weeks or to a control group. Researchers measure changes in daily activity, cardiorespiratory fitness, body fat, blood lipids, and psychological well-being over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pedal-assist electric bicycle (e-bike) commuting
What this could lead to
If it works, this could show that e-bike commuting is a practical way for overweight young adults to boost physical activity and improve heart health.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The 12-week intervention is short, and long-term adherence is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Aug 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-29 years * Currently enrolled undergraduate or graduate student * Body mass index (BMI) ≥25.0 kg/m² (classified as overweight or obese) * Self-report of engaging in \<150 minutes per week of moderate-to-vigorous physical activity * Able and willing to safely ride a bicycle for commuting or transportation purposes * Willing to be randomized and complete all study procedures across 24 weeks Able to provide informed consent Exclusion Criteria: * Current use of a bicycle or e-bike for commuting ≥2 times per week * Known cardiovascular, metabolic, or orthopedic conditions that limit physical activity or make exercise testing unsafe * Currently pregnant, planning pregnancy during the study period, or less than 6 months postpartum * Use of medications known to affect glucose metabolism, heart rate, or physical activity (e.g., beta-blockers, insulin) * Diagnosed severe mental health disorders that would impair study participation * Participation in another clinical trial or lifestyle intervention within the past 3 months * Inability or unwillingness to attend lab visits or comply with the intervention protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiometabolic risk are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Behavior Motor Activity Obesity obesity disorder Overweight Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiometabolic risk Obesity &amp; overweight Physical inactivity Sedentary behaviors

Contacts and locations

Locations

  • University of Wisconsin-River Falls

    River Falls, Wisconsin, 54022, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.